XML 16 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Net revenues $ 57,427,701 $ 44,048,740
Costs and expenses:    
Cost of services 48,735,537 34,000,786
General and administrative 18,583,372 16,962,687
Depreciation and amortization 645,742 351,396
Total costs and expenses 67,964,651 51,314,869
Loss from operations (10,536,950) (7,266,129)
Other income (expense) :    
Interest expense (82,905) (542,296)
Gain (loss) on change in fair value of warrant and conversion feature liabilities 1,633,333 (408,692)
Gain on deconsolidation of variable interest entity 242,411 0
Loss on debt extinguishment 0 (266,366)
Other income 14,701 239,057
Total other income (expense), net 1,807,540 (978,297)
Loss before benefit from income taxes (8,729,410) (8,244,426)
Benefit from income taxes (47,495) (71,037)
Net loss (8,681,915) (8,173,389)
Net income attributable to noncontrolling interests 287,901 1,170,655
Net loss attributable to Apollo Medical Holdings, Inc. $ (8,969,816) $ (9,344,044)
Net loss per share:    
Basic and diluted $ (1.49) $ (1.79)
Weighted average shares of common stock outstanding:    
Basic and diluted 6,001,680 5,212,927